Publications by authors named "Mark Pallansch"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

4,308,512

Total Likes

92,359

Extended Reach

6,030,545

Social Features

429
A
Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trial.
Cynthia J Snider, Khalequ Zaman, Concepcion F Estivariz, Asma Binte Aziz, Mohammad Yunus, Mark A Pallansch

Vaccine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worst-case scenarios: Modeling uncontrolled type 2 polio transmission.
Dominika A Kalkowska, Eric Wiesen, Steven G F Wassilak, Cara C Burns, Mark A Pallansch

Risk Anal· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences.
Dominika A Kalkowska, Steven G F Wassilak, Eric Wiesen, Cara C Burns, Mark A Pallansch

Risk Anal· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.
Amanda L Wilkinson, Khalequ Zaman, Masuma Hoque, Concepcion F Estivariz, Cara C Burns, Mark A Pallansch

Lancet Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial.
Cynthia J Snider, Khalequ Zaman, Amanda L Wilkinson, Asma Binte Aziz, Mohammad Yunus, Mark A Pallansch

Vaccine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of disruptions caused by the COVID-19 pandemic on global polio eradication.
Dominika A Kalkowska, Arend Voorman, Mark A Pallansch, Steven G F Wassilak, Stephen L Cochi

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
Dominika A Kalkowska, Mark A Pallansch, Steven G F Wassilak, Stephen L Cochi, Kimberly M Thompson

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal.
Vachagan Harutyunyan, Arshad Quddus, Mark Pallansch, Simona Zipursky, David Woods

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outbreak response strategies with type 2-containing oral poliovirus vaccines.
Dominika A Kalkowska, Steven G F Wassilak, Mark A Pallansch, Cara C Burns, Eric Wiesen

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020.
Roopa Darwar, Oladayo Biya, Sharon A Greene, Jaume Jorba, Mohammad Al Safadi, Mark A Pallansch

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Poliovirus in New York - New Instance of an Old Problem.
Mark A Pallansch

N Engl J Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine Options.
Dominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, Kimberly M Thompson

J Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial.
Khalequ Zaman, Stephanie D Kovacs, Kristin Vanderende, Asma Aziz, Mohammed Yunus, Mark A Pallansch

Vaccine· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Poliovirus Surveillance and Immunization Campaign Quality Monitoring Costs for Pakistan and Afghanistan for 2019-2023.
Dominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, Kimberly M Thompson

Open Forum Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Transmission of Live Polioviruses: Updated Dynamic Modeling of the Polio Endgame.
Dominika A Kalkowska, Mark A Pallansch, Steven G F Wassilak, Stephen L Cochi, Kimberly M Thompson

Risk Anal· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria.
Dominika A Kalkowska, Richard Franka, Jeff Higgins, Stephanie D Kovacs, Joseph C Forbi, Mark A Pallansch

Risk Anal· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated Characterization of Post-OPV Cessation Risks: Lessons from 2019 Serotype 2 Outbreaks and Implications for the Probability of OPV Restart.
Dominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, Stephanie D Kovacs, Steven G F Wassilak

Risk Anal· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain.
Dominika A Kalkowska, Mark A Pallansch, Amanda Wilkinson, Ananda S Bandyopadhyay, Jennifer L Konopka-Anstadt

Risk Anal· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Long and Winding Road to Eradicate Vaccine-Related Polioviruses.
Stephen L Cochi, Mark A Pallansch

J Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress Toward Poliovirus Containment Implementation - Worldwide, 2019-2020.
Daphne B Moffett, Anna Llewellyn, Harpal Singh, Eugene Saxentoff, Jeffrey Partridge, Mark Pallansch

MMWR Morb Mortal Wkly Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients.
Sharla L McDonald, William C Weldon, Ling Wei, Qi Chen, Jing Shaw, Mark A Pallansch

Vaccine· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Flaccid Myelitis in the United States: 2015-2017.
Tracy Ayers, Adriana Lopez, Adria Lee, Anita Kambhampati, W Allan Nix, Mark A Pallansch

Pediatrics· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2018-June 2019.
Jaume Jorba, Ousmane M Diop, Jane Iber, Elizabeth Henderson, Kun Zhao, Mark A Pallansch

MMWR Morb Mortal Wkly Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial.
Cynthia J Snider, Khalequ Zaman, Concepcion F Estivariz, Mohammad Yunus, William C Weldon, Mark A Pallansch

Lancet· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis